Inactive Instrument
IRLAB Therapeutics AB Stock Nasdaq Stockholm
Stocks
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Nasdaq Stockholm
|
||
| - SEK | - |
|
| Sep. 03 | Irlab CEO Kristina Torfgaard to step down in 2027 | FW |
| Sep. 03 | Irlab CEO Kristina Torfgaard wants to step down | FW |
| Market Cap | 274M 27.32M 24.11M 22.81M 20.69M 38.78M 2.62B 39.16M 105M 1.34B 103M 100M 4.31B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 274M 27.32M 24.11M 22.81M 20.69M 38.78M 2.62B 39.16M 105M 1.34B 103M 100M 4.31B | EV / Sales 2026 * |
2.7x | EV / Sales 2027 * | 1.91x |
| Free-Float |
83.4% | Yield 2026 * |
-
| Yield 2027 * | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 2024-07-31 | |
Susanna Waters
PRN | Corporate Officer/Principal | 60 | 2012-12-31 |
Clas Sonesson
CTO | Chief Tech/Sci/R&D Officer | 65 | 2015-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Rein Piir
BRD | Director/Board Member | 68 | 2015-12-31 |
| Chairman | 73 | 2020-05-06 | |
Veronica Wallin
BRD | Director/Board Member | 40 | 2022-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.55% | +2.66% | +54.87% | +119.52% | 1,056B | |
| +0.14% | -0.57% | +44.34% | +72.50% | 645B | |
| +0.23% | -0.60% | +13.79% | +77.73% | 465B | |
| -1.58% | -0.54% | +75.48% | +43.62% | 368B | |
| -0.13% | -3.91% | +34.28% | +40.70% | 335B | |
| -0.13% | +2.65% | +20.58% | +29.29% | 275B | |
| -0.76% | -0.94% | +10.11% | +12.45% | 255B | |
| +0.15% | +3.96% | +49.60% | +58.52% | 229B | |
| -0.58% | -0.95% | +35.07% | +102.33% | 188B | |
| Average | -0.25% | +0.12% | +37.57% | +61.85% | 423.98B | |
| Weighted average by Cap. | -0.08% | +0.30% | +41.51% | +74.07% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 101M 10.1M 8.92M 8.44M 7.65M 14.34M 969M 14.48M 39M 495M 37.94M 37.11M 1.59B | 143M 14.3M 12.62M 11.94M 10.83M 20.3M 1.37B 20.5M 55.19M 701M 53.68M 52.51M 2.25B |
| Net income | -36.1M -3.6M -3.18M -3.01M -2.73M -5.12M -346M -5.17M -13.91M -177M -13.53M -13.24M -568M | 34.6M 3.45M 3.05M 2.88M 2.62M 4.9M 331M 4.95M 13.34M 169M 12.97M 12.69M 545M |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
Calendar
Nov. 10
Earnings release - Q3 2026
Select your edition
All financial news and data tailored to specific country editions
